Supplementary Figure 1 . List of transgenic mouse strains. Transgenes used in this study are listed alphabetically, along with the type of allele, their experimental purpose, the source from which they were obtained for this study, and the papers in which the transgenes were originally described. Supplementary Figure 2 . List of primary antibodies for immunohistochemistry. Primary antibodies were used at the indicated dilutions. Where available, multiple antibodies were used to validate antibody specificity. Immunogen information is provided by the vendor.
Supplementary Figure 3. Basis Pontis is the most proliferative region of postnatal brainstem.
CD1 wild type mice received a single dose of BrdU 100 min before perfusion. Immunofluorescent BrdU staining was detected by confocal microscopy. Proliferation density was computed as number of BrdU + nuclei divided by tissue area.
All data points represent mean ± SEM of n = 3 mice; P-values based on 2-way ANOVA and Bonferroni post hoc adjustment. * P < 0.05; ** P < 0.01; *** P < 0.001; n.s. P > 0.05. (a-e) Sections in the coronal plane illustrate the levels of brainstem represented in (f-h). (f) Basis pontis is more proliferative than both ventral medulla (F 1,32 =11.53, P = 0.0108) and dorsal medulla (F 1,32 =25.14, P < 0.0006). (g) Basis pontis is more proliferative than ventral midbrain (F 1,32 =78.16, P < 0.0006), midbrain tegmentum (F 1,32 =122.34, P < 0.0006), and midbrain tectum (F 1,32 =8.87, P = 0.0330). (h) Pontine tegmentum is more proliferative than midbrain tegmentum (F 1,32 =11.86, P = 0.0032), but not dorsal medulla (F 1,32 =0.07, P = 0.7918).
Supplementary Figure 4. Postnatal pontine proliferation is non-neurogenic. (a)
CD1 wild type mice were given BrdU at 50mg/kg every 12 hrs from P0.5 through P4, then EdU at an equimolar dose (41 mg/kg) every 12 hrs from P4.5 through P8, and perfused 28 days following treatment. (b-c) Pons tissue from mice prepared as in (a) Additional experiments involving BrdU/EdU treatment between P8.5-P16, P16.5-P24, P24.5-P32, P0 (single dose BrdU), or P4 (single dose BrdU), followed by 28-day chase period in each case, also yielded no NeuN + XdU + pons cells. Scale bar = 10 µm. (e) CD1 wild-type mice were given BrdU in a single dose of 50 mg/kg 100 minutes prior to perfusion. (f) Pons tissue from mice prepared as in (e) was co-stained for BrdU, doublecortin (DCX), and polysialated neural cell adhesion molecule (PSA-NCAM). Shown here is basis pontis. No clear colocalization was observed between BrdU and either DCX or PSA-NCAM. Scale bar = 10 µm. (g) CD1 wildtype mice received a four-day course of BrdU by intraperitoneal injections at 50mg/kg every 12 hours from P4.5 to P8, and were perfused 100 minutes following the last dose of BrdU. (h) Pons tissue from mice prepared as in (g) was stained for BrdU, Olig2, and APC; shown here is basis pontis. Scale bar = 10 µm. (i) The proportion of OLPs (Olig2 + APC -cells) that were BrdU + after the 4-day pulse was greater in basis pontis than in tegmentum (P = 0.0146, unpaired t-test), consistent with findings of denser proliferation among basis pontis OLPs (Fig. 7d) and greater fold expansion among basis pontis oligodendroglia (Fig. 4f) .
Supplementary Figure 5. Expression of intermediate filaments along 4 th ventricle and midline at P4.
Sections of CD1 wildtype mouse pons tissue aged P4 were co-stained for vimentin, nestin, and GFAP, revealing partly overlapping expression patterns among the three intermediate filaments. Furthermore, the Olig2 + subpopulation is a small proportion of total ALDH1L1:GFP + BrdU + cells, except in P0 tegmentum.
